Clinical Trials Browser

OTHER × 2'-((4'-trifluoromethanesulfonyloxy)phenyl)-N-methanesulfonylpropionamide × Clear all

NCT05815173 2025-12-30

Ladarixin With Sotorasib in Advanced NSCLC

Phase 1 Recruiting

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

NCT05815186 2024-03-29

Ladarixin With Sotorasib in Advanced NSCLC - Phase II

Phase 2 Withdrawn

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation